nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—Oedema—Fluorouracil—pancreatic cancer	0.000959	0.00162	CcSEcCtD
Treprostinil—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000955	0.00162	CcSEcCtD
Treprostinil—Anorexia—Irinotecan—pancreatic cancer	0.000955	0.00162	CcSEcCtD
Treprostinil—Infection—Fluorouracil—pancreatic cancer	0.000953	0.00161	CcSEcCtD
Treprostinil—Pain in extremity—Epirubicin—pancreatic cancer	0.00095	0.00161	CcSEcCtD
Treprostinil—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000939	0.00159	CcSEcCtD
Treprostinil—Dizziness—Tamoxifen—pancreatic cancer	0.000939	0.00159	CcSEcCtD
Treprostinil—Tachycardia—Fluorouracil—pancreatic cancer	0.000936	0.00159	CcSEcCtD
Treprostinil—Hypotension—Irinotecan—pancreatic cancer	0.000936	0.00159	CcSEcCtD
Treprostinil—Anorexia—Gemcitabine—pancreatic cancer	0.00093	0.00158	CcSEcCtD
Treprostinil—Dizziness—Erlotinib—pancreatic cancer	0.000929	0.00157	CcSEcCtD
Treprostinil—Anorexia—Fluorouracil—pancreatic cancer	0.000915	0.00155	CcSEcCtD
Treprostinil—Hypotension—Gemcitabine—pancreatic cancer	0.000912	0.00154	CcSEcCtD
Treprostinil—Insomnia—Irinotecan—pancreatic cancer	0.000906	0.00153	CcSEcCtD
Treprostinil—Flushing—Docetaxel—pancreatic cancer	0.000905	0.00153	CcSEcCtD
Treprostinil—Vomiting—Tamoxifen—pancreatic cancer	0.000903	0.00153	CcSEcCtD
Treprostinil—Cardiac failure—Doxorubicin—pancreatic cancer	0.000901	0.00153	CcSEcCtD
Treprostinil—Paraesthesia—Irinotecan—pancreatic cancer	0.000899	0.00152	CcSEcCtD
Treprostinil—Hypotension—Fluorouracil—pancreatic cancer	0.000896	0.00152	CcSEcCtD
Treprostinil—Rash—Tamoxifen—pancreatic cancer	0.000895	0.00152	CcSEcCtD
Treprostinil—Dermatitis—Tamoxifen—pancreatic cancer	0.000894	0.00151	CcSEcCtD
Treprostinil—Vomiting—Erlotinib—pancreatic cancer	0.000893	0.00151	CcSEcCtD
Treprostinil—Dyspnoea—Irinotecan—pancreatic cancer	0.000893	0.00151	CcSEcCtD
Treprostinil—Headache—Tamoxifen—pancreatic cancer	0.000889	0.00151	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000889	0.00151	CcSEcCtD
Treprostinil—Rash—Erlotinib—pancreatic cancer	0.000886	0.0015	CcSEcCtD
Treprostinil—Dermatitis—Erlotinib—pancreatic cancer	0.000885	0.0015	CcSEcCtD
Treprostinil—Dehydration—Epirubicin—pancreatic cancer	0.000884	0.0015	CcSEcCtD
Treprostinil—Insomnia—Gemcitabine—pancreatic cancer	0.000883	0.00149	CcSEcCtD
Treprostinil—Dyspepsia—Irinotecan—pancreatic cancer	0.000882	0.00149	CcSEcCtD
Treprostinil—Headache—Erlotinib—pancreatic cancer	0.00088	0.00149	CcSEcCtD
Treprostinil—Pain in extremity—Doxorubicin—pancreatic cancer	0.000879	0.00149	CcSEcCtD
Treprostinil—Paraesthesia—Gemcitabine—pancreatic cancer	0.000876	0.00148	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000874	0.00148	CcSEcCtD
Treprostinil—Asthenia—Sunitinib—pancreatic cancer	0.000873	0.00148	CcSEcCtD
Treprostinil—Decreased appetite—Irinotecan—pancreatic cancer	0.000871	0.00147	CcSEcCtD
Treprostinil—Dyspnoea—Gemcitabine—pancreatic cancer	0.00087	0.00147	CcSEcCtD
Treprostinil—Insomnia—Fluorouracil—pancreatic cancer	0.000868	0.00147	CcSEcCtD
Treprostinil—Hypokalaemia—Epirubicin—pancreatic cancer	0.000865	0.00146	CcSEcCtD
Treprostinil—Fatigue—Irinotecan—pancreatic cancer	0.000864	0.00146	CcSEcCtD
Treprostinil—Paraesthesia—Fluorouracil—pancreatic cancer	0.000861	0.00146	CcSEcCtD
Treprostinil—Pruritus—Sunitinib—pancreatic cancer	0.00086	0.00146	CcSEcCtD
Treprostinil—Pain—Irinotecan—pancreatic cancer	0.000857	0.00145	CcSEcCtD
Treprostinil—Dyspnoea—Fluorouracil—pancreatic cancer	0.000855	0.00145	CcSEcCtD
Treprostinil—Erythema—Docetaxel—pancreatic cancer	0.000848	0.00144	CcSEcCtD
Treprostinil—Decreased appetite—Gemcitabine—pancreatic cancer	0.000848	0.00144	CcSEcCtD
Treprostinil—Dyspepsia—Fluorouracil—pancreatic cancer	0.000845	0.00143	CcSEcCtD
Treprostinil—Nausea—Tamoxifen—pancreatic cancer	0.000843	0.00143	CcSEcCtD
Treprostinil—Fatigue—Gemcitabine—pancreatic cancer	0.000841	0.00142	CcSEcCtD
Treprostinil—Pain—Gemcitabine—pancreatic cancer	0.000834	0.00141	CcSEcCtD
Treprostinil—Nausea—Erlotinib—pancreatic cancer	0.000834	0.00141	CcSEcCtD
Treprostinil—Decreased appetite—Fluorouracil—pancreatic cancer	0.000834	0.00141	CcSEcCtD
Treprostinil—Diarrhoea—Sunitinib—pancreatic cancer	0.000832	0.00141	CcSEcCtD
Treprostinil—Feeling abnormal—Irinotecan—pancreatic cancer	0.000825	0.0014	CcSEcCtD
Treprostinil—Influenza—Epirubicin—pancreatic cancer	0.000821	0.00139	CcSEcCtD
Treprostinil—Back pain—Docetaxel—pancreatic cancer	0.000821	0.00139	CcSEcCtD
Treprostinil—Pain—Fluorouracil—pancreatic cancer	0.00082	0.00139	CcSEcCtD
Treprostinil—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000819	0.00139	CcSEcCtD
Treprostinil—Dehydration—Doxorubicin—pancreatic cancer	0.000818	0.00138	CcSEcCtD
Treprostinil—Muscle spasms—Docetaxel—pancreatic cancer	0.000816	0.00138	CcSEcCtD
Treprostinil—Dizziness—Sunitinib—pancreatic cancer	0.000804	0.00136	CcSEcCtD
Treprostinil—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000804	0.00136	CcSEcCtD
Treprostinil—Hypokalaemia—Doxorubicin—pancreatic cancer	0.0008	0.00136	CcSEcCtD
Treprostinil—Abdominal pain—Irinotecan—pancreatic cancer	0.000792	0.00134	CcSEcCtD
Treprostinil—Body temperature increased—Irinotecan—pancreatic cancer	0.000792	0.00134	CcSEcCtD
Treprostinil—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000791	0.00134	CcSEcCtD
Treprostinil—Bronchitis—Epirubicin—pancreatic cancer	0.00079	0.00134	CcSEcCtD
Treprostinil—Anaemia—Docetaxel—pancreatic cancer	0.000784	0.00133	CcSEcCtD
Treprostinil—Vomiting—Sunitinib—pancreatic cancer	0.000773	0.00131	CcSEcCtD
Treprostinil—Body temperature increased—Gemcitabine—pancreatic cancer	0.000771	0.00131	CcSEcCtD
Treprostinil—Rash—Sunitinib—pancreatic cancer	0.000767	0.0013	CcSEcCtD
Treprostinil—Dermatitis—Sunitinib—pancreatic cancer	0.000766	0.0013	CcSEcCtD
Treprostinil—Headache—Sunitinib—pancreatic cancer	0.000762	0.00129	CcSEcCtD
Treprostinil—Syncope—Docetaxel—pancreatic cancer	0.000761	0.00129	CcSEcCtD
Treprostinil—Influenza—Doxorubicin—pancreatic cancer	0.00076	0.00129	CcSEcCtD
Treprostinil—Body temperature increased—Fluorouracil—pancreatic cancer	0.000758	0.00128	CcSEcCtD
Treprostinil—Palpitations—Docetaxel—pancreatic cancer	0.00075	0.00127	CcSEcCtD
Treprostinil—Loss of consciousness—Docetaxel—pancreatic cancer	0.000746	0.00126	CcSEcCtD
Treprostinil—Cough—Docetaxel—pancreatic cancer	0.00074	0.00125	CcSEcCtD
Treprostinil—Pneumonia—Epirubicin—pancreatic cancer	0.000737	0.00125	CcSEcCtD
Treprostinil—Bronchitis—Doxorubicin—pancreatic cancer	0.000731	0.00124	CcSEcCtD
Treprostinil—Arthralgia—Docetaxel—pancreatic cancer	0.000722	0.00122	CcSEcCtD
Treprostinil—Myalgia—Docetaxel—pancreatic cancer	0.000722	0.00122	CcSEcCtD
Treprostinil—Chest pain—Docetaxel—pancreatic cancer	0.000722	0.00122	CcSEcCtD
Treprostinil—Nausea—Sunitinib—pancreatic cancer	0.000722	0.00122	CcSEcCtD
Treprostinil—Asthenia—Irinotecan—pancreatic cancer	0.000719	0.00122	CcSEcCtD
Treprostinil—Urinary tract infection—Epirubicin—pancreatic cancer	0.000712	0.00121	CcSEcCtD
Treprostinil—Asthenia—Gemcitabine—pancreatic cancer	0.0007	0.00119	CcSEcCtD
Treprostinil—Haematuria—Epirubicin—pancreatic cancer	0.000698	0.00118	CcSEcCtD
Treprostinil—Oedema—Docetaxel—pancreatic cancer	0.000692	0.00117	CcSEcCtD
Treprostinil—Epistaxis—Epirubicin—pancreatic cancer	0.000691	0.00117	CcSEcCtD
Treprostinil—Pruritus—Gemcitabine—pancreatic cancer	0.00069	0.00117	CcSEcCtD
Treprostinil—Infection—Docetaxel—pancreatic cancer	0.000688	0.00117	CcSEcCtD
Treprostinil—Sinusitis—Epirubicin—pancreatic cancer	0.000687	0.00116	CcSEcCtD
Treprostinil—Diarrhoea—Irinotecan—pancreatic cancer	0.000685	0.00116	CcSEcCtD
Treprostinil—Pneumonia—Doxorubicin—pancreatic cancer	0.000682	0.00115	CcSEcCtD
Treprostinil—Shock—Docetaxel—pancreatic cancer	0.000681	0.00115	CcSEcCtD
Treprostinil—Pruritus—Fluorouracil—pancreatic cancer	0.000679	0.00115	CcSEcCtD
Treprostinil—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000678	0.00115	CcSEcCtD
Treprostinil—Tachycardia—Docetaxel—pancreatic cancer	0.000676	0.00114	CcSEcCtD
Treprostinil—Bradycardia—Epirubicin—pancreatic cancer	0.000669	0.00113	CcSEcCtD
Treprostinil—Diarrhoea—Gemcitabine—pancreatic cancer	0.000668	0.00113	CcSEcCtD
Treprostinil—Dizziness—Irinotecan—pancreatic cancer	0.000662	0.00112	CcSEcCtD
Treprostinil—Haemoglobin—Epirubicin—pancreatic cancer	0.000661	0.00112	CcSEcCtD
Treprostinil—Anorexia—Docetaxel—pancreatic cancer	0.00066	0.00112	CcSEcCtD
Treprostinil—Rhinitis—Epirubicin—pancreatic cancer	0.000659	0.00112	CcSEcCtD
Treprostinil—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000659	0.00112	CcSEcCtD
Treprostinil—Haemorrhage—Epirubicin—pancreatic cancer	0.000657	0.00111	CcSEcCtD
Treprostinil—Diarrhoea—Fluorouracil—pancreatic cancer	0.000656	0.00111	CcSEcCtD
Treprostinil—Pharyngitis—Epirubicin—pancreatic cancer	0.000652	0.0011	CcSEcCtD
Treprostinil—Oedema peripheral—Epirubicin—pancreatic cancer	0.000648	0.0011	CcSEcCtD
Treprostinil—Hypotension—Docetaxel—pancreatic cancer	0.000647	0.0011	CcSEcCtD
Treprostinil—Haematuria—Doxorubicin—pancreatic cancer	0.000646	0.00109	CcSEcCtD
Treprostinil—Epistaxis—Doxorubicin—pancreatic cancer	0.000639	0.00108	CcSEcCtD
Treprostinil—Vomiting—Irinotecan—pancreatic cancer	0.000637	0.00108	CcSEcCtD
Treprostinil—Sinusitis—Doxorubicin—pancreatic cancer	0.000636	0.00108	CcSEcCtD
Treprostinil—Dizziness—Fluorouracil—pancreatic cancer	0.000634	0.00107	CcSEcCtD
Treprostinil—Rash—Irinotecan—pancreatic cancer	0.000632	0.00107	CcSEcCtD
Treprostinil—Dermatitis—Irinotecan—pancreatic cancer	0.000631	0.00107	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000631	0.00107	CcSEcCtD
Treprostinil—Headache—Irinotecan—pancreatic cancer	0.000628	0.00106	CcSEcCtD
Treprostinil—Insomnia—Docetaxel—pancreatic cancer	0.000626	0.00106	CcSEcCtD
Treprostinil—Paraesthesia—Docetaxel—pancreatic cancer	0.000622	0.00105	CcSEcCtD
Treprostinil—Vomiting—Gemcitabine—pancreatic cancer	0.00062	0.00105	CcSEcCtD
Treprostinil—Bradycardia—Doxorubicin—pancreatic cancer	0.000619	0.00105	CcSEcCtD
Treprostinil—Dyspnoea—Docetaxel—pancreatic cancer	0.000617	0.00105	CcSEcCtD
Treprostinil—Rash—Gemcitabine—pancreatic cancer	0.000615	0.00104	CcSEcCtD
Treprostinil—Dermatitis—Gemcitabine—pancreatic cancer	0.000615	0.00104	CcSEcCtD
Treprostinil—Haemoglobin—Doxorubicin—pancreatic cancer	0.000611	0.00104	CcSEcCtD
Treprostinil—Headache—Gemcitabine—pancreatic cancer	0.000611	0.00104	CcSEcCtD
Treprostinil—Flushing—Epirubicin—pancreatic cancer	0.00061	0.00103	CcSEcCtD
Treprostinil—Vomiting—Fluorouracil—pancreatic cancer	0.00061	0.00103	CcSEcCtD
Treprostinil—Rhinitis—Doxorubicin—pancreatic cancer	0.00061	0.00103	CcSEcCtD
Treprostinil—Dyspepsia—Docetaxel—pancreatic cancer	0.00061	0.00103	CcSEcCtD
Treprostinil—Haemorrhage—Doxorubicin—pancreatic cancer	0.000608	0.00103	CcSEcCtD
Treprostinil—Rash—Fluorouracil—pancreatic cancer	0.000605	0.00102	CcSEcCtD
Treprostinil—Dermatitis—Fluorouracil—pancreatic cancer	0.000604	0.00102	CcSEcCtD
Treprostinil—Pharyngitis—Doxorubicin—pancreatic cancer	0.000604	0.00102	CcSEcCtD
Treprostinil—Decreased appetite—Docetaxel—pancreatic cancer	0.000602	0.00102	CcSEcCtD
Treprostinil—Headache—Fluorouracil—pancreatic cancer	0.000601	0.00102	CcSEcCtD
Treprostinil—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000599	0.00101	CcSEcCtD
Treprostinil—Fatigue—Docetaxel—pancreatic cancer	0.000597	0.00101	CcSEcCtD
Treprostinil—Nausea—Irinotecan—pancreatic cancer	0.000595	0.00101	CcSEcCtD
Treprostinil—Pain—Docetaxel—pancreatic cancer	0.000592	0.001	CcSEcCtD
Treprostinil—Nausea—Gemcitabine—pancreatic cancer	0.00058	0.000982	CcSEcCtD
Treprostinil—Erythema—Epirubicin—pancreatic cancer	0.000572	0.000969	CcSEcCtD
Treprostinil—Feeling abnormal—Docetaxel—pancreatic cancer	0.000571	0.000966	CcSEcCtD
Treprostinil—Nausea—Fluorouracil—pancreatic cancer	0.00057	0.000965	CcSEcCtD
Treprostinil—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000566	0.000959	CcSEcCtD
Treprostinil—Flushing—Doxorubicin—pancreatic cancer	0.000565	0.000956	CcSEcCtD
Treprostinil—Tension—Epirubicin—pancreatic cancer	0.000562	0.000951	CcSEcCtD
Treprostinil—Nervousness—Epirubicin—pancreatic cancer	0.000556	0.000941	CcSEcCtD
Treprostinil—Back pain—Epirubicin—pancreatic cancer	0.000554	0.000937	CcSEcCtD
Treprostinil—Muscle spasms—Epirubicin—pancreatic cancer	0.00055	0.000932	CcSEcCtD
Treprostinil—Body temperature increased—Docetaxel—pancreatic cancer	0.000547	0.000927	CcSEcCtD
Treprostinil—Abdominal pain—Docetaxel—pancreatic cancer	0.000547	0.000927	CcSEcCtD
Treprostinil—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000531	0.000899	CcSEcCtD
Treprostinil—Erythema—Doxorubicin—pancreatic cancer	0.00053	0.000897	CcSEcCtD
Treprostinil—Anaemia—Epirubicin—pancreatic cancer	0.000529	0.000896	CcSEcCtD
Treprostinil—Tension—Doxorubicin—pancreatic cancer	0.00052	0.00088	CcSEcCtD
Treprostinil—Malaise—Epirubicin—pancreatic cancer	0.000516	0.000874	CcSEcCtD
Treprostinil—Nervousness—Doxorubicin—pancreatic cancer	0.000514	0.000871	CcSEcCtD
Treprostinil—Syncope—Epirubicin—pancreatic cancer	0.000513	0.000869	CcSEcCtD
Treprostinil—Back pain—Doxorubicin—pancreatic cancer	0.000512	0.000867	CcSEcCtD
Treprostinil—Muscle spasms—Doxorubicin—pancreatic cancer	0.000509	0.000862	CcSEcCtD
Treprostinil—Palpitations—Epirubicin—pancreatic cancer	0.000506	0.000856	CcSEcCtD
Treprostinil—Loss of consciousness—Epirubicin—pancreatic cancer	0.000503	0.000852	CcSEcCtD
Treprostinil—Cough—Epirubicin—pancreatic cancer	0.000499	0.000846	CcSEcCtD
Treprostinil—Asthenia—Docetaxel—pancreatic cancer	0.000497	0.000841	CcSEcCtD
Treprostinil—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000491	0.000832	CcSEcCtD
Treprostinil—Pruritus—Docetaxel—pancreatic cancer	0.00049	0.00083	CcSEcCtD
Treprostinil—Anaemia—Doxorubicin—pancreatic cancer	0.000489	0.000829	CcSEcCtD
Treprostinil—Arthralgia—Epirubicin—pancreatic cancer	0.000487	0.000825	CcSEcCtD
Treprostinil—Chest pain—Epirubicin—pancreatic cancer	0.000487	0.000825	CcSEcCtD
Treprostinil—Myalgia—Epirubicin—pancreatic cancer	0.000487	0.000825	CcSEcCtD
Treprostinil—Anxiety—Epirubicin—pancreatic cancer	0.000486	0.000822	CcSEcCtD
Treprostinil—Discomfort—Epirubicin—pancreatic cancer	0.000481	0.000815	CcSEcCtD
Treprostinil—Malaise—Doxorubicin—pancreatic cancer	0.000478	0.000809	CcSEcCtD
Treprostinil—Syncope—Doxorubicin—pancreatic cancer	0.000475	0.000804	CcSEcCtD
Treprostinil—Diarrhoea—Docetaxel—pancreatic cancer	0.000474	0.000802	CcSEcCtD
Treprostinil—Palpitations—Doxorubicin—pancreatic cancer	0.000468	0.000792	CcSEcCtD
Treprostinil—Oedema—Epirubicin—pancreatic cancer	0.000467	0.000791	CcSEcCtD
Treprostinil—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000465	0.000788	CcSEcCtD
Treprostinil—Infection—Epirubicin—pancreatic cancer	0.000464	0.000786	CcSEcCtD
Treprostinil—Cough—Doxorubicin—pancreatic cancer	0.000462	0.000783	CcSEcCtD
Treprostinil—Shock—Epirubicin—pancreatic cancer	0.00046	0.000778	CcSEcCtD
Treprostinil—Dizziness—Docetaxel—pancreatic cancer	0.000458	0.000775	CcSEcCtD
Treprostinil—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000457	0.000774	CcSEcCtD
Treprostinil—Tachycardia—Epirubicin—pancreatic cancer	0.000456	0.000772	CcSEcCtD
Treprostinil—Arthralgia—Doxorubicin—pancreatic cancer	0.000451	0.000763	CcSEcCtD
Treprostinil—Chest pain—Doxorubicin—pancreatic cancer	0.000451	0.000763	CcSEcCtD
Treprostinil—Myalgia—Doxorubicin—pancreatic cancer	0.000451	0.000763	CcSEcCtD
Treprostinil—Anxiety—Doxorubicin—pancreatic cancer	0.000449	0.000761	CcSEcCtD
Treprostinil—Discomfort—Doxorubicin—pancreatic cancer	0.000445	0.000754	CcSEcCtD
Treprostinil—Anorexia—Epirubicin—pancreatic cancer	0.000445	0.000754	CcSEcCtD
Treprostinil—Vomiting—Docetaxel—pancreatic cancer	0.00044	0.000746	CcSEcCtD
Treprostinil—Rash—Docetaxel—pancreatic cancer	0.000437	0.000739	CcSEcCtD
Treprostinil—Hypotension—Epirubicin—pancreatic cancer	0.000436	0.000739	CcSEcCtD
Treprostinil—Dermatitis—Docetaxel—pancreatic cancer	0.000436	0.000739	CcSEcCtD
Treprostinil—Headache—Docetaxel—pancreatic cancer	0.000434	0.000735	CcSEcCtD
Treprostinil—Oedema—Doxorubicin—pancreatic cancer	0.000432	0.000732	CcSEcCtD
Treprostinil—Infection—Doxorubicin—pancreatic cancer	0.000429	0.000727	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000426	0.000721	CcSEcCtD
Treprostinil—Shock—Doxorubicin—pancreatic cancer	0.000425	0.00072	CcSEcCtD
Treprostinil—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000423	0.000717	CcSEcCtD
Treprostinil—Insomnia—Epirubicin—pancreatic cancer	0.000422	0.000715	CcSEcCtD
Treprostinil—Tachycardia—Doxorubicin—pancreatic cancer	0.000422	0.000714	CcSEcCtD
Treprostinil—Paraesthesia—Epirubicin—pancreatic cancer	0.000419	0.00071	CcSEcCtD
Treprostinil—Dyspnoea—Epirubicin—pancreatic cancer	0.000416	0.000705	CcSEcCtD
Treprostinil—Anorexia—Doxorubicin—pancreatic cancer	0.000412	0.000698	CcSEcCtD
Treprostinil—Nausea—Docetaxel—pancreatic cancer	0.000411	0.000697	CcSEcCtD
Treprostinil—Dyspepsia—Epirubicin—pancreatic cancer	0.000411	0.000696	CcSEcCtD
Treprostinil—Decreased appetite—Epirubicin—pancreatic cancer	0.000406	0.000688	CcSEcCtD
Treprostinil—Hypotension—Doxorubicin—pancreatic cancer	0.000404	0.000684	CcSEcCtD
Treprostinil—Fatigue—Epirubicin—pancreatic cancer	0.000403	0.000682	CcSEcCtD
Treprostinil—Pain—Epirubicin—pancreatic cancer	0.000399	0.000676	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—GLI1—pancreatic cancer	0.000395	0.000966	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—DTX4—pancreatic cancer	0.000395	0.000966	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	0.000394	0.000963	CbGpPWpGaD
Treprostinil—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000394	0.000667	CcSEcCtD
Treprostinil—P2RY12—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000393	0.000959	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CNR1—pancreatic cancer	0.000392	0.000958	CbGpPWpGaD
Treprostinil—Insomnia—Doxorubicin—pancreatic cancer	0.000391	0.000662	CcSEcCtD
Treprostinil—Paraesthesia—Doxorubicin—pancreatic cancer	0.000388	0.000657	CcSEcCtD
Treprostinil—P2RY12—Signaling by GPCR—CNR1—pancreatic cancer	0.000387	0.000946	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCKBR—pancreatic cancer	0.000387	0.000945	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—PIK3CG—pancreatic cancer	0.000387	0.000945	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—SST—pancreatic cancer	0.000386	0.000943	CbGpPWpGaD
Treprostinil—Dyspnoea—Doxorubicin—pancreatic cancer	0.000385	0.000652	CcSEcCtD
Treprostinil—PPARD—Metabolism—GLP1R—pancreatic cancer	0.000385	0.000941	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000385	0.00094	CbGpPWpGaD
Treprostinil—Feeling abnormal—Epirubicin—pancreatic cancer	0.000385	0.000652	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—NRP1—pancreatic cancer	0.000385	0.000939	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000385	0.000939	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—EZH2—pancreatic cancer	0.000384	0.000936	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—EGF—pancreatic cancer	0.000382	0.000934	CbGpPWpGaD
Treprostinil—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000382	0.000647	CcSEcCtD
Treprostinil—Dyspepsia—Doxorubicin—pancreatic cancer	0.00038	0.000644	CcSEcCtD
Treprostinil—CYP2C9—Arachidonic acid metabolism—PTGS2—pancreatic cancer	0.00038	0.000928	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—GCG—pancreatic cancer	0.000379	0.000926	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—DPYD—pancreatic cancer	0.000379	0.000925	CbGpPWpGaD
Treprostinil—Decreased appetite—Doxorubicin—pancreatic cancer	0.000376	0.000636	CcSEcCtD
Treprostinil—PPARD—Gene Expression—NOTCH3—pancreatic cancer	0.000375	0.000917	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—GCG—pancreatic cancer	0.000374	0.000913	CbGpPWpGaD
Treprostinil—Fatigue—Doxorubicin—pancreatic cancer	0.000373	0.000631	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—HEY2—pancreatic cancer	0.00037	0.000904	CbGpPWpGaD
Treprostinil—Pain—Doxorubicin—pancreatic cancer	0.00037	0.000626	CcSEcCtD
Treprostinil—Body temperature increased—Epirubicin—pancreatic cancer	0.000369	0.000625	CcSEcCtD
Treprostinil—Abdominal pain—Epirubicin—pancreatic cancer	0.000369	0.000625	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—DTX4—pancreatic cancer	0.000364	0.000889	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—GLI1—pancreatic cancer	0.000364	0.000889	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—GAST—pancreatic cancer	0.000362	0.000883	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000362	0.000883	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—SLC2A2—pancreatic cancer	0.00036	0.000878	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—AGTR1—pancreatic cancer	0.000357	0.000871	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CNR1—pancreatic cancer	0.000356	0.00087	CbGpPWpGaD
Treprostinil—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000356	0.000603	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—PIK3CG—pancreatic cancer	0.000356	0.000869	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	0.000356	0.000869	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—HSPA1A—pancreatic cancer	0.000355	0.000868	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NRP1—pancreatic cancer	0.000354	0.000864	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000354	0.000864	CbGpPWpGaD
Treprostinil—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000353	0.000598	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—EGF—pancreatic cancer	0.000352	0.000859	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	0.000351	0.000856	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—GCG—pancreatic cancer	0.000344	0.00084	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	0.000343	0.000839	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SCT—pancreatic cancer	0.000343	0.000837	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HEY1—pancreatic cancer	0.000343	0.000837	CbGpPWpGaD
Treprostinil—Abdominal pain—Doxorubicin—pancreatic cancer	0.000342	0.000579	CcSEcCtD
Treprostinil—Body temperature increased—Doxorubicin—pancreatic cancer	0.000342	0.000579	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—HEY2—pancreatic cancer	0.000341	0.000832	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—PIK3CD—pancreatic cancer	0.00034	0.00083	CbGpPWpGaD
Treprostinil—Asthenia—Epirubicin—pancreatic cancer	0.000335	0.000568	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—GAST—pancreatic cancer	0.000333	0.000813	CbGpPWpGaD
Treprostinil—Pruritus—Epirubicin—pancreatic cancer	0.00033	0.00056	CcSEcCtD
Treprostinil—PTGIR—Signaling by GPCR—AGTR1—pancreatic cancer	0.000328	0.000802	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCK—pancreatic cancer	0.000327	0.000799	CbGpPWpGaD
Treprostinil—Diarrhoea—Epirubicin—pancreatic cancer	0.00032	0.000541	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—CNR2—pancreatic cancer	0.000319	0.000778	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—GLP1R—pancreatic cancer	0.000319	0.000778	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—CXCL8—pancreatic cancer	0.000319	0.000778	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HEY1—pancreatic cancer	0.000316	0.00077	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SCT—pancreatic cancer	0.000316	0.00077	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCKAR—pancreatic cancer	0.000314	0.000766	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—PIK3CD—pancreatic cancer	0.000313	0.000764	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	0.000313	0.000764	CbGpPWpGaD
Treprostinil—Asthenia—Doxorubicin—pancreatic cancer	0.00031	0.000525	CcSEcCtD
Treprostinil—Dizziness—Epirubicin—pancreatic cancer	0.000309	0.000523	CcSEcCtD
Treprostinil—Pruritus—Doxorubicin—pancreatic cancer	0.000306	0.000518	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—JAG2—pancreatic cancer	0.000304	0.000742	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCK—pancreatic cancer	0.000301	0.000735	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MEN1—pancreatic cancer	0.0003	0.000732	CbGpPWpGaD
Treprostinil—Vomiting—Epirubicin—pancreatic cancer	0.000297	0.000503	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—PIK3CB—pancreatic cancer	0.000296	0.000724	CbGpPWpGaD
Treprostinil—Diarrhoea—Doxorubicin—pancreatic cancer	0.000296	0.000501	CcSEcCtD
Treprostinil—Rash—Epirubicin—pancreatic cancer	0.000294	0.000499	CcSEcCtD
Treprostinil—Dermatitis—Epirubicin—pancreatic cancer	0.000294	0.000498	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—CNR2—pancreatic cancer	0.000293	0.000716	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—GLP1R—pancreatic cancer	0.000293	0.000716	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—CXCL8—pancreatic cancer	0.000293	0.000716	CbGpPWpGaD
Treprostinil—Headache—Epirubicin—pancreatic cancer	0.000293	0.000496	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—CCKAR—pancreatic cancer	0.000289	0.000705	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	0.000286	0.000699	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SHH—pancreatic cancer	0.000286	0.000698	CbGpPWpGaD
Treprostinil—Dizziness—Doxorubicin—pancreatic cancer	0.000286	0.000484	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—NOTCH4—pancreatic cancer	0.000284	0.000694	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—SMAD4—pancreatic cancer	0.000283	0.00069	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IAPP—pancreatic cancer	0.000282	0.000689	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—JAG2—pancreatic cancer	0.00028	0.000683	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CD44—pancreatic cancer	0.000278	0.00068	CbGpPWpGaD
Treprostinil—Nausea—Epirubicin—pancreatic cancer	0.000277	0.00047	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—MEN1—pancreatic cancer	0.000276	0.000673	CbGpPWpGaD
Treprostinil—Vomiting—Doxorubicin—pancreatic cancer	0.000275	0.000465	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—PIK3CB—pancreatic cancer	0.000273	0.000666	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	0.000273	0.000666	CbGpPWpGaD
Treprostinil—Rash—Doxorubicin—pancreatic cancer	0.000272	0.000461	CcSEcCtD
Treprostinil—Dermatitis—Doxorubicin—pancreatic cancer	0.000272	0.000461	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—PTHLH—pancreatic cancer	0.000271	0.000662	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PTCH1—pancreatic cancer	0.000271	0.000662	CbGpPWpGaD
Treprostinil—Headache—Doxorubicin—pancreatic cancer	0.000271	0.000458	CcSEcCtD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	0.00027	0.00066	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GCG—pancreatic cancer	0.000267	0.000652	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SHH—pancreatic cancer	0.000263	0.000642	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NOTCH4—pancreatic cancer	0.000261	0.000638	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IAPP—pancreatic cancer	0.00026	0.000634	CbGpPWpGaD
Treprostinil—Nausea—Doxorubicin—pancreatic cancer	0.000257	0.000435	CcSEcCtD
Treprostinil—PPARD—Metabolism—STK11—pancreatic cancer	0.000251	0.000613	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PTHLH—pancreatic cancer	0.000249	0.000609	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PTCH1—pancreatic cancer	0.000249	0.000609	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SST—pancreatic cancer	0.000248	0.000605	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000244	0.000597	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—JAG1—pancreatic cancer	0.000243	0.000592	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NOTCH3—pancreatic cancer	0.000242	0.00059	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—SRC—pancreatic cancer	0.000238	0.00058	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	0.000236	0.000575	CbGpPWpGaD
Treprostinil—PPARD—Generic Transcription Pathway—MYC—pancreatic cancer	0.000233	0.000569	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—VEGFA—pancreatic cancer	0.000231	0.000565	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CNR1—pancreatic cancer	0.000229	0.000559	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—NRAS—pancreatic cancer	0.000229	0.000558	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SST—pancreatic cancer	0.000228	0.000557	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000225	0.000549	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—JAG1—pancreatic cancer	0.000223	0.000545	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NOTCH3—pancreatic cancer	0.000222	0.000543	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000222	0.000542	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—GCG—pancreatic cancer	0.000221	0.000539	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—SRC—pancreatic cancer	0.000219	0.000534	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—TYMS—pancreatic cancer	0.000216	0.000527	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000215	0.000525	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—VEGFA—pancreatic cancer	0.000213	0.00052	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—TGFB1—pancreatic cancer	0.000212	0.000519	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AGTR1—pancreatic cancer	0.000211	0.000515	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CNR1—pancreatic cancer	0.000211	0.000514	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—NRAS—pancreatic cancer	0.00021	0.000514	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—NOTCH1—pancreatic cancer	0.000208	0.000509	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—STK11—pancreatic cancer	0.000208	0.000507	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000204	0.000499	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—GCG—pancreatic cancer	0.000203	0.000496	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000198	0.000483	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—PPARG—pancreatic cancer	0.000197	0.00048	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—KRAS—pancreatic cancer	0.000197	0.00048	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—TGFB1—pancreatic cancer	0.000195	0.000477	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000195	0.000477	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AGTR1—pancreatic cancer	0.000194	0.000474	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—STK11—pancreatic cancer	0.000191	0.000467	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000187	0.000457	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SMAD4—pancreatic cancer	0.000182	0.000444	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—KRAS—pancreatic cancer	0.000181	0.000442	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—PIK3CA—pancreatic cancer	0.000181	0.000441	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—CXCL8—pancreatic cancer	0.00018	0.00044	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PIK3CD—pancreatic cancer	0.00018	0.000439	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HES1—pancreatic cancer	0.000178	0.000434	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—APOE—pancreatic cancer	0.000176	0.000429	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—TP53—pancreatic cancer	0.000175	0.000427	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000172	0.000421	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PIK3CB—pancreatic cancer	0.00017	0.000415	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SMAD4—pancreatic cancer	0.000167	0.000409	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—HRAS—pancreatic cancer	0.000167	0.000408	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—PIK3CA—pancreatic cancer	0.000166	0.000406	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	0.000166	0.000406	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000166	0.000405	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HES1—pancreatic cancer	0.000163	0.000399	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CXCL8—pancreatic cancer	0.000163	0.000399	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—TP53—pancreatic cancer	0.000161	0.000393	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PIK3CG—pancreatic cancer	0.000158	0.000387	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000157	0.000382	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TERT—pancreatic cancer	0.000156	0.00038	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—HRAS—pancreatic cancer	0.000154	0.000376	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PPARG—pancreatic cancer	0.000153	0.000373	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CXCL8—pancreatic cancer	0.00015	0.000367	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HIF1A—pancreatic cancer	0.000149	0.000364	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TSC2—pancreatic cancer	0.000148	0.000363	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—AKT1—pancreatic cancer	0.000148	0.00036	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—APOE—pancreatic cancer	0.000145	0.000355	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TERT—pancreatic cancer	0.000143	0.00035	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—KDR—pancreatic cancer	0.000142	0.000348	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PIK3CD—pancreatic cancer	0.000139	0.00034	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HIF1A—pancreatic cancer	0.000137	0.000335	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TSC2—pancreatic cancer	0.000137	0.000334	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—AKT1—pancreatic cancer	0.000136	0.000332	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NFKBIA—pancreatic cancer	0.000135	0.000331	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NOTCH1—pancreatic cancer	0.000134	0.000327	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—APOE—pancreatic cancer	0.000134	0.000327	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PIK3CG—pancreatic cancer	0.000131	0.00032	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—NRAS—pancreatic cancer	0.000131	0.00032	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—KDR—pancreatic cancer	0.000131	0.00032	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—EGF—pancreatic cancer	0.00013	0.000317	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PRSS1—pancreatic cancer	0.000127	0.00031	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NFKBIA—pancreatic cancer	0.000125	0.000304	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NOTCH1—pancreatic cancer	0.000123	0.000301	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PIK3CB—pancreatic cancer	0.000121	0.000297	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PIK3CG—pancreatic cancer	0.000121	0.000295	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—NRAS—pancreatic cancer	0.000121	0.000295	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PTGS2—pancreatic cancer	0.00012	0.000294	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—EGFR—pancreatic cancer	0.000119	0.000292	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—EGF—pancreatic cancer	0.000119	0.000291	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PIK3CD—pancreatic cancer	0.000115	0.000282	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000114	0.000279	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—KRAS—pancreatic cancer	0.000113	0.000276	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—MYC—pancreatic cancer	0.000112	0.000274	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—EGFR—pancreatic cancer	0.00011	0.000269	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ARG2—pancreatic cancer	0.00011	0.000268	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PIK3CD—pancreatic cancer	0.000106	0.000259	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000105	0.000257	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PTEN—pancreatic cancer	0.000105	0.000256	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—KRAS—pancreatic cancer	0.000104	0.000254	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000104	0.000253	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PIK3CB—pancreatic cancer	0.0001	0.000245	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CXCL8—pancreatic cancer	9.66e-05	0.000236	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—TYMP—pancreatic cancer	9.61e-05	0.000235	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—HRAS—pancreatic cancer	9.59e-05	0.000234	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PIK3CA—pancreatic cancer	9.54e-05	0.000233	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—AKT1—pancreatic cancer	9.33e-05	0.000228	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PIK3CB—pancreatic cancer	9.25e-05	0.000226	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CASP3—pancreatic cancer	9.24e-05	0.000226	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCND1—pancreatic cancer	9e-05	0.00022	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CTNNB1—pancreatic cancer	8.91e-05	0.000218	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CXCL8—pancreatic cancer	8.89e-05	0.000217	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—HRAS—pancreatic cancer	8.83e-05	0.000216	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MMP9—pancreatic cancer	8.73e-05	0.000213	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PTEN—pancreatic cancer	8.68e-05	0.000212	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—AKT1—pancreatic cancer	8.58e-05	0.00021	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CASP3—pancreatic cancer	8.51e-05	0.000208	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—AKT1—pancreatic cancer	8.47e-05	0.000207	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCND1—pancreatic cancer	8.28e-05	0.000202	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CTNNB1—pancreatic cancer	8.2e-05	0.0002	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SRC—pancreatic cancer	8.05e-05	0.000197	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MMP9—pancreatic cancer	8.04e-05	0.000196	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PTEN—pancreatic cancer	7.99e-05	0.000195	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	7.93e-05	0.000194	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—VEGFA—pancreatic cancer	7.84e-05	0.000192	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—AKT1—pancreatic cancer	7.8e-05	0.00019	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—AKT1—pancreatic cancer	7.78e-05	0.00019	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—STAT3—pancreatic cancer	7.77e-05	0.00019	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NRAS—pancreatic cancer	7.75e-05	0.000189	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GLP1R—pancreatic cancer	7.74e-05	0.000189	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—DPYD—pancreatic cancer	7.62e-05	0.000186	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SRC—pancreatic cancer	7.41e-05	0.000181	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PIK3CA—pancreatic cancer	7.4e-05	0.000181	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	7.23e-05	0.000177	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—VEGFA—pancreatic cancer	7.22e-05	0.000176	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MYC—pancreatic cancer	7.22e-05	0.000176	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TGFB1—pancreatic cancer	7.2e-05	0.000176	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	7.16e-05	0.000175	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—STAT3—pancreatic cancer	7.15e-05	0.000175	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NRAS—pancreatic cancer	7.13e-05	0.000174	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—EGFR—pancreatic cancer	7.06e-05	0.000172	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	6.91e-05	0.000169	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—KRAS—pancreatic cancer	6.67e-05	0.000163	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MYC—pancreatic cancer	6.64e-05	0.000162	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TGFB1—pancreatic cancer	6.62e-05	0.000162	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—EGFR—pancreatic cancer	6.5e-05	0.000159	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	6.29e-05	0.000154	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—KRAS—pancreatic cancer	6.14e-05	0.00015	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PIK3CA—pancreatic cancer	6.13e-05	0.00015	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—AKT1—pancreatic cancer	6.05e-05	0.000148	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TP53—pancreatic cancer	5.93e-05	0.000145	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HRAS—pancreatic cancer	5.67e-05	0.000138	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PIK3CA—pancreatic cancer	5.64e-05	0.000138	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CD44—pancreatic cancer	5.6e-05	0.000137	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.48e-05	0.000134	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TP53—pancreatic cancer	5.45e-05	0.000133	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.43e-05	0.000133	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GCG—pancreatic cancer	5.37e-05	0.000131	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HRAS—pancreatic cancer	5.22e-05	0.000127	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—STK11—pancreatic cancer	5.05e-05	0.000123	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AKT1—pancreatic cancer	5e-05	0.000122	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.74e-05	0.000116	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AKT1—pancreatic cancer	4.61e-05	0.000112	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—TYMS—pancreatic cancer	4.34e-05	0.000106	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—APOE—pancreatic cancer	3.53e-05	8.62e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.34e-05	8.16e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	3.19e-05	7.78e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PPARG—pancreatic cancer	3.08e-05	7.51e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	2.8e-05	6.84e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	2.44e-05	5.96e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PTGS2—pancreatic cancer	2.42e-05	5.91e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PTEN—pancreatic cancer	2.11e-05	5.15e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1.49e-05	3.63e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—AKT1—pancreatic cancer	1.22e-05	2.97e-05	CbGpPWpGaD
